Author: Tomas Lindqvist

US Republican senators call for an investigation into Chinese criminal organizations’ alleged involvement in the US cannabis and hemp industries, citing illicit…

Dutch medical cannabis pioneer Bedrocan faces bankruptcy following the end of its state contract and delayed legislative reform. Thousands of patients are…

Asia-Pacific cannabis producers often overlook critical EU-GMP compliance for Germany. Learn why European Qualified Persons are key to market access.

The CHAMPS Vegas Summer Show 2026 adapted to US hemp regulation uncertainty, showcasing new cannabis beverage brands and a resilient industry spirit.

New Mexico’s Medical Psilocybin Program begins accepting producer permit applications, marking a critical step towards therapeutic access for qualifying patients.

UK employers must apply existing duty of care and disability laws to medical cannabis patients, ensuring fair assessment and reasonable adjustments in…

Illinois officials propose a rule change to allow outdoor commercial cannabis cultivation. This could significantly reduce costs and expand canopy for licensed…

Germany’s recent health insurance reform has thrown medical cannabis reimbursement into disarray, affecting patients and pharmacies alike. Learn about the shifting rules…

Curaleaf’s unsolicited bid for Aurora Cannabis signals a major consolidation in the European medical cannabis market, highlighting strategic shifts and growth in…

California’s DCC issued a voluntary recall for a cannabis product. Packaging with a figurine violated rules by being attractive to children. Consumers…